US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

261.85

-0.4300-0.16%

Post-market: 261.850.00000.00%19:30 EDT

Volume:30.06K

Turnover:7.90M

Market Cap:2.84B

PE:30.64

High:264.97

Open:264.46

Low:261.85

Close:262.28

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.98

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.02

PE(LYR):6.94

Loading ...

Overview Company News Filings

Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development

THOMSON REUTERS

Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management

THOMSON REUTERS

Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues

THOMSON REUTERS

NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion

Grail announces FDA advisory committee meeting to review Galleri test PMA

De Dietrich Joins PIPAC Consortium to Develop Continuous API Manufacturing Platform

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400

The Race to Come up with the Next Big Sleep Drug

Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks

Simply Wall St.

Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion

Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

Simply Wall St.

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bruker (BRKR) Receives a Buy from Wells Fargo

Bruker Corporation : Stifel Raises Target Price to $50 from $45

THOMSON REUTERS

Bruker Corporation : Leerink Partners Cuts Target Price to $60 from $70

THOMSON REUTERS

Bruker (BRKR) Stock Price Sinks After Goodwill Hit Triggers Loss

Simply Wall St.

Bruker Down Nearly 20%, on Track for Largest Percent Decrease Since December 2008

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/FBT/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":261.85,"timestamp":1789156800000,"preClose":262.28,"halted":0,"volume":30061,"hourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0016394692694828047,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Market Closed","change":-0.43,"latestTime":"09-11 16:00:00 EDT","open":264.46,"high":264.965,"low":261.85,"amount":7900544.843099999,"amplitude":0.011877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":262.28,"sharesOutstanding":11450002,"nav":262.39,"aum":2860051524.78,"bidAskSpread":0.001063,"preHourTrading":{"tag":"盘前","latestPrice":262.28,"preClose":262.28,"latestTime":"08:18 EDT","volume":1,"amount":262.28,"timestamp":1789129101219,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":261.85,"preClose":261.85,"latestTime":"19:30 EDT","volume":15,"amount":3926.22,"timestamp":1789169408690,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9828931233249508,"impliedVol":0.2371,"impliedVolPercentile":0.8725},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.9828931233249508,"shares":10850002,"dividePrice":0,"high":264.965,"amplitude":0.011877,"preClose":262.28,"low":261.85,"week52Low":173.975,"pbRate":"1.02","psRate":"685.38","week52High":274.99,"institutionHeld":0,"latestPrice":261.85,"eps":8.545272,"divideRate":0,"volume":30061,"delay":0,"ttmEps":8.545272,"open":264.46,"prevYearClose":206.52,"prevWeekClose":270.93,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":273.79,"twentyDayClose":256.07,"sixtyDayClose":226.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658980054","title":"Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980054?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","LU0757428866.USD","BRKR","BK4121","LU1815336091.USD","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938953","title":"Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938953?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BRKR","LU1815336091.USD","FBT","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658389549","title":"Bruker Corporation - Mimetas Provides Scalable Organ-on-a-Chip Solutions for Human-Relevant Tissues","url":"https://stock-news.laohu8.com/highlight/detail?id=2658389549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658389549?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA49P62Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU0757428866.USD","TINY","FBT","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621846","title":"NEO Battery Amends $4 Million LIFE Offering to Fund South Korea Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621846","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621846?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:41","pubTimestamp":1786138895,"startTime":"0","endTime":"0","summary":"NEO Battery Materials Ltd ( ($TSE:NBM) ) just unveiled an announcement. NEO Battery Materials Ltd. has amended the terms of its non-brokered LIFE O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neo-battery-amends-4-million-life-offering-to-fund-south-korea-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neo-battery-amends-4-million-life-offering-to-fund-south-korea-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NEO","BK4139","BK4121","BK4173","LU0012050646.USD","LIFE","FBT","BK4196","LU0106261612.USD","BK4563","UYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","GRAL","BK4585","FBT","IBRN","BK4129","XBIX","BK4139","BBP","BK4588","LABU","PMA","PBE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657697686","title":"De Dietrich Joins PIPAC Consortium to Develop Continuous API Manufacturing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2657697686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657697686?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:51","pubTimestamp":1786085493,"startTime":"0","endTime":"0","summary":"De Dietrich joins PIPAC consortium to develop continuous API manufacturing platformDe Dietrich joined the PIPAC consortium with Alysophil, Bruker, Novalix to validate a continuous API manufacturing pl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL7SFgXp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4121","BRKR","LU1815336091.USD","LU0757428866.USD","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369495","title":"Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369495?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:11","pubTimestamp":1786083103,"startTime":"0","endTime":"0","summary":"An update from Oxford BioMedica ( ($GB:OXB) ) is now available. Oxford Biomedica, a specialist cell and gene therapy CDMO, reported around 9% reven...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","FBT","CNCR","IBB","IBBQ","SYNB","TBXU","WDNA","HELX","GNOM","LFSC","JDOC","OXM","BK4202","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520326","title":"NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520326","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520326?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:03","pubTimestamp":1786046585,"startTime":"0","endTime":"0","summary":"NeoGenomics Chief Accounting Officer Greg D. Aunan disposes of 20,000 shares for $321,400NeoGenomics Chief Accounting Officer Greg D. Aunan sold 20,000 common shares on Aug. 4 at USD 16.07.Directly he","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL64M2fb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NeoGenomics Chief Accounting Officer Greg D. Aunan Disposes of 20,000 Shares for $321,400","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","LU0012050646.USD","FBT","BK4121","LU0106261612.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651052","title":"The Race to Come up with the Next Big Sleep Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651052?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:30","pubTimestamp":1786041000,"startTime":"0","endTime":"0","summary":"Narcolepsy isn't easy to treat. Existing drugs manage patients' symptoms -- notably excessive daytime sleepiness and difficulty sleeping at night -- rather than the cause. Yet a new type of drug is em","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","IE00BN29S564.USD","LU0238689110.USD","LU0323591593.USD","IE00BKPKM429.USD","LU0097036916.USD","LU2023250330.USD","SG9999014914.USD","IE00BJJMRX11.SGD","LU0882574139.USD","LU0096364046.USD","LU1868837136.USD","LU2168564065.EUR","LU2023251221.USD","IE00BWXC8680.SGD","LU2746668974.SGD","TRUH","LU0256863902.USD","XLV","SG9999018865.SGD","SG9999018857.SGD","LU2471134952.CNY","LU0943347566.SGD","LU1323610961.USD","LU0109394709.USD","LU0672654240.SGD","SG9999014880.SGD","BK4007","LU0133085943.USD","IE0004445239.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0823434583.USD","LU2063271972.USD","SG9999015986.USD","LU2357305700.SGD","WDNA","LU2491049909.HKD","LU0109391861.USD","LU0787776722.HKD","LU1145028129.USD","BK4588","LU1988902786.USD","LU2236285917.USD","ILDR","LU0122379950.USD","LU2602419157.SGD","HRTS","LU2237438978.USD","LU2361044865.SGD","LU1712237335.SGD","LU0354030438.USD","ELIS","LU2462591350.SGD","LU0114720955.EUR","FTXH","CANC","IE00BJLML261.HKD","LU1868836757.USD","TAK","LU0820562030.AUD","IE00B1XK9C88.USD","LU0174119429.USD","LU0708995401.HKD","LU2237443895.HKD","LU2168564495.EUR","BK4516","LU1280957306.USD","BK4581","LU2491050071.SGD","AGNG","IE00BJJMRY28.SGD","IYH","LU1629891620.HKD","LU2746668461.USD","LU0471298777.SGD","LU0882574055.USD","BK4533","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU2089984988.USD","IE00B1BXHZ80.USD","LLII","LU1720051108.HKD","SG9999001176.SGD","CURE","LU0203202063.USD","LU0466842654.USD","LU0820561909.HKD","LU0158827781.USD","LLY","LU2361045086.USD","LU0964807845.USD","BK4534","LLYZ","LU1720051017.SGD","LU0345770993.USD","LU0225283273.USD","MHIP","THNR","FBT","LU2106854487.HKD","LU0353189680.USD","LU1035775433.USD","LU1093756325.SGD","LU2417539215.USD","LU2756315318.SGD","LU2471134879.HKD","SG9999014898.SGD","LU0432979614.USD","LU2471134523.USD","LU2237443549.SGD","LU0345770308.USD","LU2168564222.USD","PSIL","BK4599","LU2324357040.USD","LU2361044949.HKD","LU2213496289.HKD","OZEM","LU0266013472.USD","LU2111349929.HKD","LU0456855351.SGD","LU2264538146.SGD","BK4585","IXJ","LU2089283258.USD","LU2552382215.SGD","RXL","IHE","LU2237443465.HKD","LU0210536198.USD","LU0320765059.SGD","LU0385154629.USD","IE0005OL40V9.USD","LU0106261372.USD","LU2896262040.SGD","SG9999015945.SGD","LU0158827948.USD","IBRN","ELIL","LU2462157665.USD","PPH","LU2552382132.HKD","LU2552382058.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2112291526.USD","LU0417517546.SGD","IE0004445015.USD","LU0058720904.USD","LU1232071149.USD","LU0203201768.USD","LU0320765992.SGD","LU1023059063.AUD","IE00B775H168.HKD","LU2456880835.USD","LU2750360641.GBP","LU2265009873.SGD","SG9999014906.USD","LU1064131342.USD","LU1291159041.SGD","LU0061475181.USD","IE00BJJMRZ35.SGD","PJP","LU1868837300.USD","LU1061106388.HKD","GDOC","LU0006306889.USD","LU0316494557.USD","LU0823416689.USD","LU1623119135.USD","LU1804176565.USD","LU2087625088.SGD","BK4139","SG9999017495.SGD","LU1868836914.USD","LU1366192091.USD","LU1551013425.SGD","LU2168563687.JPY","IE00B4JS1V06.HKD","LU2471134796.USD","SG9999015952.SGD","LU0689472784.USD","LU1127390331.HKD","LU2237443382.USD","LU1917777945.USD","LU2237443622.USD","LU2023250504.SGD","LU1093756168.USD","SG9999013999.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU0889565916.HKD","IE0009355771.USD","LU2271345857.HKD","TMED","LU0820561818.USD","LU0354030511.USD","SG9999015978.USD","LU2461242641.AUD","LU2360106947.USD","LU2237443978.SGD","LU1868836591.USD","LU0234572021.USD","MEDI","LU2089284900.SGD","JDOC","LU0823434740.USD","FHLC","LU1989771016.USD","LU0471298694.HKD","MEDX","VHT","SGXZ31699556.SGD","LU1551013342.USD","PSCH","LU1974910355.USD","LU2108987350.USD","LU0198837287.USD","LU2491050154.USD","IE00BK4W5M84.HKD","LLYX","LU1057294990.SGD","LU2756315664.SGD","LU1983299246.USD","LU1548497426.USD","IE00BKDWB100.SGD","LU1814569148.SGD","LU0079474960.USD","LU0256863811.USD","LU1267930730.SGD","ALKS","LU0353189763.USD","LU2750360997.AUD","LU0094547139.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","IE00BK4W5L77.USD","LU0786609619.USD","LU0640476718.USD","LU2468319806.SGD","SGXZ57979304.SGD","GB00BDT5M118.USD","LU0683600562.USD","LU2168564149.EUR","LU2028103732.USD","IE00B7KXQ091.USD","LU1979441026.SGD","SG9999001176.USD","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656597","title":"Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656597","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656597?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:39","pubTimestamp":1786030757,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics stock has delivered a very large 5 year return, yet its recent valuation checks suggest the shares are not an obvious bargain at today's level.\n\nOver the past 5 years, Corcept Therapeutics has returned about 4.4x, which sets a high bar for any further upside to be justified by fundamentals.\nInvestor focus is currently on how demand for the company’s treatments and late stage pipeline can support future revenue, while execution and clinical outcomes across those programs...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/corcept-therapeutics-cort-stock-could-be-undervalued-despite","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","LU0566484027.USD","FBT","CORT","BK4532","LU1559883803.SGD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657020325","title":"Deltic Energy sets remote court hearing as NEO NEXT+ cash takeover nears completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657020325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657020325?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:12","pubTimestamp":1785996756,"startTime":"0","endTime":"0","summary":"Deltic Energy ( ($GB:DELT) ) has shared an announcement. Deltic Energy and NEO NEXT+ Energy Upstream UK have confirmed progress on NEO NEXT+’s reco...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/deltic-energy-sets-remote-court-hearing-as-neo-next-cash-takeover-nears-completion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BESF","NEO","FBT","BK4196","LU0106261612.USD","LU0012050646.USD","NEXT","BK4121","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657023575","title":"Circio’s circVec gene therapy platform secures oral slot at top European ESGCT conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2657023575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657023575?lang=en_us&edition=fundamental","pubTime":"2026-08-06 13:45","pubTimestamp":1785995139,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA, a biotechnology company specializing in circular RNA expression systems...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circios-circvec-gene-therapy-platform-secures-oral-slot-at-top-european-esgct-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","FBT","TBXU","CNCR","BK4588","LFSC","AGNG","BK4505","RNA","JDOC","RDMX","XT","BK4139","IBB","RSPH","SYNB","EPV","LNGR","FWD","GNOM","FHLC","IEIH","BBP","BK4585","DARP","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657509379","title":"How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657509379","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657509379?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:41","pubTimestamp":1785987715,"startTime":"0","endTime":"0","summary":"In late July 2026, NeoGenomics reported second-quarter 2026 results showing sales of US$201.66 million and a return to profitability with net income of US$2.24 million, alongside higher first-half revenue and a sharply reduced year-to-date net loss.\nThe company also raised its full-year 2026 revenue outlook to US$802 million–US$806 million and tightened its projected net loss range, which points to improving operating performance and greater confidence in its business trajectory.\nNext, we’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-neogenomics-q2-profit-return-and-higher-2026-outlook-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FBT","LU0012050646.USD","BK4196","LU0106261612.USD","BK4121","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571260","title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571260","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571260?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:11","pubTimestamp":1785967865,"startTime":"0","endTime":"0","summary":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL4ffvrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4007","CORT","FBT","BK4532","LU0566484027.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657256541","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657256541?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:01","pubTimestamp":1785931309,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IDEAYA Biosciences (IDYA), Bruker (BRKR) and Rhythm ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-277?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0757428866.USD","TINY","BRKR","IDYA","LU1815336091.USD","FBT","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657417615","title":"Bruker (BRKR) Receives a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657417615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657417615?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:50","pubTimestamp":1785930642,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst maintained a Buy rating on Bruker today and set a price target of $55.00. Bruker has an analyst consensus of Moderate Buy, with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bruker-brkr-receives-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KBWB","LU0149725797.USD","LU0942090050.USD","LU1267930490.SGD","IE00B19Z3581.USD","LU0289960550.SGD","IE00B19Z3B42.SGD","IYF","BK4504","LU0310800965.SGD","LU0787776722.HKD","LU0106831901.USD","LU0072461881.USD","LU0256863811.USD","LU0251131958.USD","TFNS","LU0310800379.SGD","LU1074936037.SGD","LU0742534661.SGD","LU0314106906.USD","IE000M9KFDE8.USD","LU1815336091.USD","FTXO","LU2361045086.USD","FBT","LU0708994859.HKD","LU0640476718.USD","LU1069347547.HKD","BK4207","LU0267386448.USD","PGF","LU0052756011.USD","LU1363072403.SGD","LU0971096721.USD","LU1201861249.SGD","LU1894683264.USD","LU0211328371.USD","LU0251142724.SGD","LU0029864427.USD","LU0130517989.USD","LU1035773651.USD","LU0320765489.SGD","LU1668664300.SGD","LU0070302665.USD","TINY","LU0211327993.USD","LU1267930573.SGD","IE0002270589.USD","LU0683600562.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546991","title":"Bruker Corporation : Stifel Raises Target Price to $50 from $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657546991?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:11","pubTimestamp":1785928286,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421BW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","BRKR","TINY","FBT","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657040592","title":"Bruker Corporation : Leerink Partners Cuts Target Price to $60 from $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2657040592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657040592?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:40","pubTimestamp":1785904848,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN44204O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","LU1815336091.USD","TINY","BRKR","BK4121","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657019593","title":"Bruker (BRKR) Stock Price Sinks After Goodwill Hit Triggers Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657019593","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657019593?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:41","pubTimestamp":1785886889,"startTime":"0","endTime":"0","summary":"Bruker went into this earnings print looking like a mispriced quality story, then the stock dropped 22% in a single session and shattered that calm narrative. The result that really hit investors was not the modest revenue of US$838.5m. It was the swing back into a quarterly loss, with basic earnings per share at a loss of US$0.41, driven by a US$135m non cash goodwill impairment.\nThe stock may now appear cheaper on paper, but it also presents a more complicated profit story to assess. The...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-stock-price-sinks-after-goodwill-hit-triggers-lo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-brkr/bruker/news/bruker-brkr-stock-price-sinks-after-goodwill-hit-triggers-lo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FBT","LU0757428866.USD","BK4121","TINY","LU1815336091.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356343","title":"Bruker Down Nearly 20%, on Track for Largest Percent Decrease Since December 2008","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657356343?lang=en_us&edition=fundamental","pubTime":"2026-08-05 02:03","pubTimestamp":1785866580,"startTime":"0","endTime":"0","summary":"Bruker Corporation  is currently at $51.46, down $12.86 or 19.99%--Would be lowest close since May 27, 2026, when it closed at $48.62--On pace for largest percent decrease since Dec. 1, 2008, when it fell 20.64%--Currently down three of the past five days--Up 9.22% year-to-date--Down 45.42% from its all-time closing high of $94.27 on March 21, 2024--Up 60.45% from 52 weeks ago , when it closed at $32.07--Down 20.03% from its 52-week closing high of $64.34 on July 30, 2026--Up 75.32% from its 52-week closing low of $29.35 on Sept. 3, 2025--Traded as low as $51.25; lowest intraday level since May 28, 2026, when it hit $48.95--Down 20.31% at today's intraday low; largest intraday percent decrease since July 24, 2012, when it fell as much as 25.82%All data as of 2:01:05 PM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","TINY","LU0757428866.USD","BK4121","FBT","BRKR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}